Are transferring from another provider and would like to continue their weight loss programme with us
Current Long Term Options For Patients Maintaining the current dose The Approach Maintaining the current dose means continuing the patient on their established, well tolerated GLP-1 regimen on an ongoing basis to manage obesity and any related chronic conditions
JAMA Network+1 This means that when we take your case, we dont just file generic claimswe align your medical facts with evolving science and regulatory admissions
Real-world numbers are likely higher than clinical trial data suggests
Even if GLP-1s have lower efficacy than an existing treatment (and there are indications that they may have higher efficacy), if they can reach many times more people, the overall public health impact would be massive
Semaglutide may be unsuitable or require additional caution in patients who: are pregnant, breastfeeding or trying to conceive have a history of pancreatitis have severe gastrointestinal disease have delayed stomach emptying have significant kidney or liver impairment use insulin or medicines that can cause hypoglycaemia have diabetic retinopathy have an active or previous eating disorder have experienced a serious allergic reaction to semaglutide already use another GLP-1 or GIP/GLP-1 medicine are due to undergo surgery, sedation or general anaesthesia These factors are not all automatic exclusions
.webp)
